ASA

ASA Pharma is an Irish-based pharmaceutical company specializing in the development and licensing of combination drug products for cardiovascular health. The company's primary business model focuses on creating fixed-dose combinations of established therapies to improve patient compliance and outcomes in managing cardiovascular conditions. Their lead product is a combination of bisoprolol and acetylsalicylic acid (aspirin), which is currently approved and marketed in several European and CIS markets. As a development-focused entity, ASA Pharma out-licenses its products to international pharmaceutical partners who manage the commercialization, marketing, and sales activities.